ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    Incidence of pulmonary arterial hypertension in chronic kidney disease at tertiary care hospital


    Gauswami Bhaveshgiri Surajgiri, Dharam Prakash Bansal, Ram Kishan Jat, Puneet Rijhwani, Kishore Moolrajani, Priyank Shah
    JCDR. 2023: 914-917

    Abstract

    The incidence of pulmonary hypertension (PAH) in chronic kidney disease (CKD) in Indian patients has been evaluated in this study. In addition, association of PAH with CKD etiology, Association between the severity of PAH with CKD duration, various related biochemical parameters, and their relation to PAH in CKD patients were analyzed. This cross-sectional study included 101 CKD patients. Detailed history and clinical examination were recorded. Hemoglobin, blood urea nitrogen (BUN), serum creatinine, albumin, and calcium-phosphorus product were recorded. Pulmonary function test was evaluated and two-dimensional echo was done 4 hours post dialysis. Introduction: Chronic kidney disease (CKD) is a worldwide public health problem both in form of burden of disease and treatment cost. CKD leads to various comorbidities that mark patients of all stages of the disease, currently relationship has been found between HD and Pulmonary Arterial Hypertension. Aims and Objectives: To study incidence of Pulmonary Arterial Hypertension in chronic kidney disease patients. And To study association of chronic kidney disease stages with Pulmonary arterial hypertension Results: The Incidence of PAH in CKD patients was 61.39%. PAH was more common in males (69.3%). The Incidence of PAH increased as CKD stage advanced (p<0.001). The Incidence (p = 0.001) and severity (p = 0.05) of PH increased with increase in CKD duration. The Incidence of PAH in CKD patients was 61.39%. There was a positive correlation between PAH and duration of CKD, duration of HD and Stages of CKD

    Description

    .

    » PDF

    Volume & Issue

    Volume 14 Issue 5

    Keywords

    .